Across TCGA pan-cancer cohorts, DAP mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of DAP’s most consistent transcriptional readouts.
The strongest signal is observed in lung adenocarcinoma (LUAD), where DAP mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types DAP is over-expressed in tumor, although a few such as PDAC and CCRCC show the opposite, repressed pattern.
LUAD, COAD, and PDAC are the cancer types where DAP tumor–normal differential expression is most reproducible.